Concepedia

Meijian Zhou

MZ

22

Publications

900

Citations

18

H-Index

2008

Active since

Affiliations

Karolinska Institutet(Current)

Covance (United States)

University of Rochester

Danderyds sjukhus

Center for Drug Evaluation and Research

Meijian Zhou is an author at Karolinska Institutet specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

2008–2020

22

Publications

22

Results From the IQ‐CSRC Prospective Study Support Replacement of the Thorough QT Study by QT Assessment in the Early Clinical Phase

Börje Darpö, Charles Benson, Corina Dota et al. · Clinical Pharmacology & Therapeutics · 2015 · 176 citations · Full text

Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults

Yanchun Che, Xiaoqiang Liu, Yi Pu et al. · Clinical Infectious Diseases · 2020 · 72 citations · Full text

Ascending Single‐Dose, Double‐Blind, Placebo‐Controlled Safety Study of Noribogaine in Opioid‐Dependent Patients

Paul Glue, Gavin Cape, Donna Tunnicliff et al. · Clinical Pharmacology in Drug Development · 2016 · 59 citations

Safety, pharmacokinetics, pharmacogenomics and <scp>QT</scp> concentration−effect modelling of the <scp>SirT1</scp> inhibitor selisistat in healthy volunteers

Göran Westerberg, Joseph Chiesa, Claus A. Andersen et al. · British Journal of Clinical Pharmacology · 2014 · 58 citations · Full text

Detection of QTc Effects in Small Studies—Implications for Replacing the Thorough QT Study

Georg Ferber, Meijian Zhou, Börje Darpö · Annals of Noninvasive Electrocardiology · 2014 · 58 citations · Full text

Rows per page

1–5 of 22